Caravelle International Group Regains Compliance with Nasdaq Minimum Bid Price Requirement
C Ray Therapeutics Completes Over $100 Million Series A+ Financing, Jointly Led by SCGC and TaiLong Capital
Is China taking advantage of China-U.S. trade?
Massimo Announces Expansion of Successful Partnership with Rural King for 2025
MSI Powers AI & HPC at SC24 with NVIDIA MGX™ AI Servers and Intel® Xeon® 6 DC-MHS Server Solutions
Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC
Jiangxi: Thriving on New Growth Drivers
Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets
